HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Science-Backed Products, Better User Experience Sell Self-Care – Bayer Consumer Research Chief

Executive Summary

Self-care within next decade should help consumers prevent common ailments, says Bayer consumer health research executive Dave Evendon-Challis. Bayer aims to steer consumers into effective self-care using credible science behind its products and improving the user experience.

You may also be interested in...



Bayer Suggests Self-Care Industry Follow Five Principles As 'Blueprint' For Product Development

Bayer proposes five science-based principles to guide industry’s self-care research and development to reframe self-care and earn consumer trust.

HBW Insight’s Key Takeaways From 2021: #3 Keep Your Eye On AI

The future of digital health will be shaped more than anything else by the rise of artificial intelligence. From body enhancing bio-wearables to camera-based skin diagnostics, the consumer health industry continued to explore the possibilities presented by AI in 2021. However, there are many regulatory and ethical hurdles industry must overcome as we move into 2022 and beyond.

People On The Move: Appointments At Bayer And Sanofi

The latest consumer health industry appointments: Bayer has hired Ricardo Salazar Hernández from Sanofi as its chief medical officer; Sanofi has promoted Alberto Hernandez Lopez to the role of chief growth officer.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151380

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel